BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 31673282)

  • 1. CRISPR/Cas9-mediated LMP1 knockout inhibits Epstein-Barr virus infection and nasopharyngeal carcinoma cell growth.
    Huo H; Hu G
    Infect Agent Cancer; 2019; 14():30. PubMed ID: 31673282
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Regulation of DNA Damage Signaling and Cell Death Responses by Epstein-Barr Virus Latent Membrane Protein 1 (LMP1) and LMP2A in Nasopharyngeal Carcinoma Cells.
    Wasil LR; Wei L; Chang C; Lan L; Shair KH
    J Virol; 2015 Aug; 89(15):7612-24. PubMed ID: 25972552
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CD47 Overexpression Is Associated with Epstein-Barr Virus Infection and Poor Prognosis in Patients with Nasopharyngeal Carcinoma.
    Wang ZH; Pei XF; Zhu ZQ; Lin Z; Mao YY; Xu XL; Luo YL; Zhang L; Peng PJ
    Onco Targets Ther; 2020; 13():3325-3334. PubMed ID: 32368091
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High mobility group box 1 (HMGB1) is upregulated by the Epstein-Barr virus infection and promotes the proliferation of human nasopharyngeal carcinoma cells.
    Zhu X; Sun L; Wang Y
    Acta Otolaryngol; 2016; 136(1):87-94. PubMed ID: 26382001
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Generation of novel affibody molecules targeting the EBV LMP2A N-terminal domain with inhibiting effects on the proliferation of nasopharyngeal carcinoma cells.
    Zhu J; Kamara S; Cen D; Tang W; Gu M; Ci X; Chen J; Wang L; Zhu S; Jiang P; Chen S; Xue X; Zhang L
    Cell Death Dis; 2020 Apr; 11(4):213. PubMed ID: 32238802
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epstein-Barr Virus_Encoded LMP1 upregulates microRNA-21 to promote the resistance of nasopharyngeal carcinoma cells to cisplatin-induced Apoptosis by suppressing PDCD4 and Fas-L.
    Yang GD; Huang TJ; Peng LX; Yang CF; Liu RY; Huang HB; Chu QQ; Yang HJ; Huang JL; Zhu ZY; Qian CN; Huang BJ
    PLoS One; 2013; 8(10):e78355. PubMed ID: 24194922
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epstein-Barr virus-encoded LMP2A regulates viral and cellular gene expression by modulation of the NF-kappaB transcription factor pathway.
    Stewart S; Dawson CW; Takada K; Curnow J; Moody CA; Sixbey JW; Young LS
    Proc Natl Acad Sci U S A; 2004 Nov; 101(44):15730-5. PubMed ID: 15498875
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Activation of sterol regulatory element-binding protein 1 (SREBP1)-mediated lipogenesis by the Epstein-Barr virus-encoded latent membrane protein 1 (LMP1) promotes cell proliferation and progression of nasopharyngeal carcinoma.
    Lo AK; Lung RW; Dawson CW; Young LS; Ko CW; Yeung WW; Kang W; To KF; Lo KW
    J Pathol; 2018 Oct; 246(2):180-190. PubMed ID: 29968360
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interleukins, laminin and Epstein - Barr virus latent membrane protein 1 (EBV LMP1) promote metastatic phenotype in nasopharyngeal carcinoma.
    Chew MM; Gan SY; Khoo AS; Tan EL
    BMC Cancer; 2010 Oct; 10():574. PubMed ID: 20964870
    [TBL] [Abstract][Full Text] [Related]  

  • 10. NF-κB Signaling Regulates Expression of Epstein-Barr Virus BART MicroRNAs and Long Noncoding RNAs in Nasopharyngeal Carcinoma.
    Verhoeven RJ; Tong S; Zhang G; Zong J; Chen Y; Jin DY; Chen MR; Pan J; Chen H
    J Virol; 2016 Jul; 90(14):6475-88. PubMed ID: 27147748
    [TBL] [Abstract][Full Text] [Related]  

  • 11. LMP1 stimulates the transcription of eIF4E to promote the proliferation, migration and invasion of human nasopharyngeal carcinoma.
    Zhao Y; Pang TY; Wang Y; Wang S; Kang HX; Ding WB; Yong WW; Bie YH; Cheng XG; Zeng C; Yao YH; Li Q; Hu XR
    FEBS J; 2014 Jul; 281(13):3004-18. PubMed ID: 24814906
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Downregulation of ATOH8 induced by EBV-encoded LMP1 contributes to the malignant phenotype of nasopharyngeal carcinoma.
    Wang Z; Xie J; Yan M; Wang J; Wang X; Zhang J; Zhang Y; Li P; Lei X; Huang Q; Lin S; Guo X; Liu Q
    Oncotarget; 2016 May; 7(18):26765-79. PubMed ID: 27049918
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epstein-Barr virus infection in precursor lesions of nasopharyngeal carcinoma.
    Zhong BL; Zong YS; Lin SX; Zhang M; Liang YJ
    Ai Zheng; 2006 Feb; 25(2):136-42. PubMed ID: 16480574
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Novel EBV LMP1 C-terminal domain binding affibody molecules as potential agents for in vivo molecular imaging diagnosis of nasopharyngeal carcinoma.
    Kamara S; Guo Y; Mao S; Ye X; Li Q; Zheng M; Zhu J; Zhang J; Du W; Chen J; Zhu S; Zhang L
    Appl Microbiol Biotechnol; 2021 Oct; 105(19):7283-7293. PubMed ID: 34505914
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Modulation of LMP2A expression by a newly identified Epstein-Barr virus-encoded microRNA miR-BART22.
    Lung RW; Tong JH; Sung YM; Leung PS; Ng DC; Chau SL; Chan AW; Ng EK; Lo KW; To KF
    Neoplasia; 2009 Nov; 11(11):1174-84. PubMed ID: 19881953
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Targeting Epstein-Barr virus oncoprotein LMP1-mediated glycolysis sensitizes nasopharyngeal carcinoma to radiation therapy.
    Xiao L; Hu ZY; Dong X; Tan Z; Li W; Tang M; Chen L; Yang L; Tao Y; Jiang Y; Li J; Yi B; Li B; Fan S; You S; Deng X; Hu F; Feng L; Bode AM; Dong Z; Sun LQ; Cao Y
    Oncogene; 2014 Sep; 33(37):4568-78. PubMed ID: 24662831
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epstein-Barr virus latent gene transcription in nasopharyngeal carcinoma cells: coexpression of EBNA1, LMP1, and LMP2 transcripts.
    Brooks L; Yao QY; Rickinson AB; Young LS
    J Virol; 1992 May; 66(5):2689-97. PubMed ID: 1313894
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mitogen- and stress-activated Kinase 1 mediates Epstein-Barr virus latent membrane protein 1-promoted cell transformation in nasopharyngeal carcinoma through its induction of Fra-1 and c-Jun genes.
    Li B; Wan Z; Huang G; Huang Z; Zhang X; Liao D; Luo S; He Z
    BMC Cancer; 2015 May; 15():390. PubMed ID: 25958199
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Latent Membrane Protein 1 Is a Novel Determinant of Epstein-Barr Virus Genome Persistence and Reactivation.
    Caves EA; Butch RM; Cook SA; Wasil LR; Chen C; Di YP; Lee N; Shair KHY
    mSphere; 2017; 2(6):. PubMed ID: 29134204
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nasopharyngeal Carcinoma: The Role of the EGFR in Epstein-Barr Virus Infection.
    Peng X; Zhou Y; Tao Y; Liu S
    Pathogens; 2021 Aug; 10(9):. PubMed ID: 34578147
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.